Sanofi opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Sanofi

Patent Number:
Title:
Streptococcus Pneumoniae Capsular Polysaccharides And Conjugates Thereof
Applicant:
Opposition Date:
Jul 11, 2024
Patent Number:
Title:
Il-15 And Il-15Ralpha Sushi Domain Based On Modulokines
Opposition Date:
Jul 4, 2024
Patent Number:
Title:
Treating Fibrosis By Inhibiting Tl1A
Opposition Date:
May 9, 2024
Patent Number:
Title:
Biosynthetic Heparin
Opposition Date:
Feb 16, 2024
Patent Number:
Title:
Artificial Nucleic Acid Molecules For Improved Protein Expression
Applicant:
Opposition Date:
Jan 26, 2024
Patent Number:
Title:
Needle Cover Assembly
Applicant:
Opposition Date:
Jan 12, 2024
Patent Number:
Title:
Small Liposomes For Delivery Of Immunogen-Encoding Rna
Opposition Date:
Nov 30, 2023
Patent Number:
Title:
Antigen Binding Proteins To Proprotein Convertase Subtilisin Kexin Type 9 (Pcsk9)
Applicant:
Opposition Date:
Nov 10, 2023
Patent Number:
Title:
Small Liposomes For Delivery Of Immunogen-Encoding Rna
Opposition Date:
Oct 9, 2023
Patent Number:
Title:
Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna
Opposition Date:
Sep 27, 2023

Latest patents of Sanofi opposed by its competitors

Patent:
Grant Date:
Oct 16, 2024
Title:
Long - Acting Formulations Of Insulins
Oppositions:
1
Patent:
Grant Date:
Nov 29, 2023
Title:
Syringe Carrier
Oppositions:
1
Patent:
Grant Date:
Nov 15, 2023
Title:
Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist
Oppositions:
6
Patent:
Grant Date:
Jul 5, 2023
Title:
Compositions And Methods Of Immunizing Against C. Difficile
Oppositions:
1
Patent:
Grant Date:
Jun 7, 2023
Title:
Data Collection Apparatus For Attachment To An Injection Device
Oppositions:
1
Patent:
Grant Date:
Jan 11, 2023
Title:
Syringe Carrier
Oppositions:
2
Patent:
Grant Date:
Aug 10, 2022
Title:
Lixisenatide Synthesis With Capping
Oppositions:
2
Patent:
Grant Date:
Jun 1, 2022
Title:
Flavivirus Vaccines
Oppositions:
2
Patent:
Grant Date:
Oct 6, 2021
Title:
Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist
Oppositions:
4
Patent:
Grant Date:
Sep 1, 2021
Title:
Methods For Treating Or Preventing Asthma By Administering An Il-4R Antagonist
Oppositions:
3

Want to track Sanofi?

Feel free to send us a message here and we will get back to you